There are few subjects in the field of respiratory disease in which careless thinking is more often encouraged by the confident use of ill-defined terms than chronic bronchitis and the morbid states associated with or consequent upon it. The reason is not far to seek. Precise definition is most readily achieved in diseases that have a single known cause and in which there are characteristic well-established morbid anatomical changes.
Chronic bronchitis, unfortunately, has a complex and multiple etiology: only recently have some of the associated morbid anatomical changes in the bronchi been described and correlated with clinical findings (Reid 1960) , and this has hitherto been done on only a small scale. Asthma is the condition most often confused with bronchitis. Although some cases of asthma have a clearly defined and even specific allergic &etiology, little is known of the morbid anatomical changesexceptin cases severe enough to die in status asthmaticus. Emphysema is often conjoined in unholy and thoughtless matrimony with the word 'bronchitis', whenever men who cough become severely breathless. Morbid anatomists have developed techniques relatively recently, whereby emphysema may be accurately diagnosed. These techniques are not widely used and we have not yet established the clinical and functional criteria by which we may diagnose emphysema during life, except in extremely severe cases.
These are our present handicaps to clear definition and classification, but despite them I think it is possible to propose definitions and a classification which is convenient and useful even though it is largely clinical and will certainly be superseded in time.
Bronchitis and emphysema must be regarded as wholly separate conditions. Each can exist without the other and although they co-exist so frequently that they probably have some causative connexion, I am bold enough to claim that we cannot always say whether either has caused the other or whether they have arisen independently.
Chronic Bronchitis
Chronic bronchitis, which I define as 'chronic or recurrent generalized, excessive secretion of bronchial mucus, sufficient to cause expectoration,' can conveniently be classified (Fletcher 1959) according to a scheme which represents a common course of progression, into the following stages:
(1) Simple chronic bronchitis: Here there is merely an increase in the amount of mucus secreted into the bronchial lumen, so that there is expectoration of mucoid sputum. Those who produce smaller amounts tend to expectorate only on rising or only later in the day, whereas those who produce larger amounts expectorate on rising and throughout the day or night . Those who produce the larger amounts appear to be more liable to recurrent chest illnesses and impaired ventilatory capacity (Fletcher & Tinker 1961) . There are many different forms of mucoid phlegm, varying from a dense grey gelatinous mass to a thin watery secretion. This is commonly thickly interset with small blobs of macrophages containing dusts, and polymorphs. Sometimes clumps of eosinophils are found which suggest an allergic basis for the hypersecretion, but we know very little about how important these differences are and what their prognostic significance may be.
(2) Chronic bronchitis with active infection: Although mucoid sputum may contain polymorphs, and pathogenic bacteria may be found both in it and in the mucosa from which it is derived, acute or active infection results in the production of purulent sputum. This may be intermittent, lasting for a week or so with systemic consequences of the infection, such as fever and malaise, or it may be persistent and devoid of much systemic disturbance. In a survey we are now carrying out, we have recently observed that men who usually pro-duce mucoid sputum may produce intensely purulent sputum on isolated days without, so far as we know, any notable clinical change in their condition. A sputum specimen on one single day may be misleading.
(3) Chronic bronchitis with airways obstruction: Here there is generalized increase of resistance to the flow of air in the bronchi, which is greater on expiration than on inspiration. At first this may cause no symptoms or signs and can only be demonstrated by physiological measurements, but when it is severe it produces rhonchi, wheezing and dyspncea. We do not know the mechanism by which the obstruction is produced but we think that secretion into the bronchiolar lumen, swelling of the mucosa and submucosa, fibrosis in the bronchial walls and perhaps muscle spasm may all be involved. It is useful to consider it as being: (a) Reversible, i.e. varying in severity either spontaneously or as a result of treatment. This type of case may well be described as asthmatic, for asthma is best defined in similar terms, namely: 'generalized airways obstruction the severity of which varies considerably from time to time, either spontaneously or under treatment' (Ciba Foundation 1959). I do not know how to distinguish an asthmatic who gets bronchitis (as described above) from a bronchitic who develops asthma. They require the same therapy and so the distinction is clinically unimportant.
(b) Irreversible, i.e. permanent and progressive without remission. It is usually in this type of case that emphysema is assumed to be present, but experience has shown that even in patients whose airways obstruction is so severe as to cause fatal respiratory failure, no emphysema may be found at autopsy.
Emphysema
Emphysema must be defined in anatomical terms (Ciba Foundation 1959) , and occurs in a variety of forms (Gough 1952) , of which the commonest are the centrilobular and panacinar types. It can be classified on both qualitative and quantitative criteria (Ciba Foundation 1959 (Higgins 1959 , Fletcher 1962 (Fletcher 1962) . It is widely thought that recurrent infection in some way damages the bronchial tree, leading to its narrow-ing, so that the bronchioles tend to collapse and obstruct air flow on expiration and this may be a cause of emphysema.
Although we find that recurrent illnesses and evidence of airways obstruction are more frequent in smokers than in non-smokers, the frequency does not increase with increasingly heavy smoking. It may be that the most susceptible tend to restrict their tobacco consumption so that the heavier smokers are, as it were, the tougher, more resistant survivors. Or it may be that smoking is only a conditioning factor, merely causing productive cough which then renders the subject more liable to hazards such as air pollution, that are more prevalent in towns than in the country. Onlypatientprospective study will permit us to follow the precise natural history of disabling chronic bronchitis, and to discover what sort of personal characteristics and external insults make the normal healthy bronchus first produce too much secretion, then develop infection and finally obstruct the free flow of air to the alveoli.
I have only mentioned smoking, air pollution and infection in the pathogenesis of chronic bronchitis, for there are no other factors about which we have clearly incriminating information. Industrial dust exposure may be important (Higgins 1960), but whether climate, damp housing, sleeping with open windows, inadequate treatment of childhood illnesses and other factors, which have been suspected by various authorities to play some part, are of any significance we do not know at present. They are all susceptible to study but it is a hard and expensive kind of research in which too few people are engaged. Meanwhile it is important both for our understanding of the disease and for the direction of our treatment, that we should distinguish the chronic bronchitic who only has mucoid phlegm, the patient who has infection, and the patient who has obstruction to bronchial air flow. For distinguishing the first two types of case it is essential and very easy to obtain a specimen of sputum in a glass container and learn to distinguish various degrees of purulence. For the diagnosis of airways obstruction it is important, though perhaps not essential, to be able to make some objective measurement of ventilatory capacity. The Wright peak flow meter (Wright & McKerrow 1959 ) provides a simple and useful way of doing this.
Emphysema: There has been much speculation about the pathogenesis of emphysema, much of it convincing, and yet we really know little more than we did fifty years ago, except that wind instrument players are not prone to it. It was found in a recent Czechoslovakian study that 'clinical emphysema' was no more frequent in such people than in the general population (Rejsek et al. 1960) . Maclean (1957) and Leopold & Gough (1957) have argued that the common centrilobular type of emphysema is likely to be due to bronchiolar inflammation -but no one has shown that it is more frequent in those with clinical and bacterial evidence of recurring infection than in those without such a history. Maclean thinks that panacinar emphysema may develop from centrilobular emphysema, though most pathologists consider it to be distinct (Heard 1958 , Wyatt 1959 . But whether it is a primary degenerative condition or is also post-inflammatory, no one yet knows. We await better clinicopathological correlations, but these are very hard to achieve. (Campbell 1958) , and surface tension changes (Mead 1961) . The net result is functional airway narrowing, which is the main cause of breathlessness and clinical deterioration in patients with chronic non-specific lung disease. These changes have still to be reconciled in detail with the pathological picture of expanded bronchioles and alveolar ducts (Cromie 1961 , Dunnill 1961 (Campbell & Howell 1960) .
At this stage a minor chest illness may, by temporarily eliminating a small area of functioning lung, precipitate congestive cardiac failure and CO2 narcosis may occur if oxygen is administered too liberally without supporting therapy. All these changes from the trivial to the most severe follow from persistent functional narrowing of the airways, its severity being reflected in the subsequent prognosis of the patient.
Prognostic Value of Tests ofLung Function
The prognostic value of the tests of lung function has been assessed from the records of patients who have attended the Pneumoconiosis Research Unit at different times. All were studied when as free from chest illness and congestive failure as could be achieved by hospitalization and intensive therapy.
The first group consisted of 235 coalminers ranging from the very fit to respiratory cripples, who were seen during the period 1947-51 and were subsequently followed up for ten years. Their prognosis is analysed with respect to the initial category of pneumoconiosis in Table 2 , where the subjects are divided into those who died (Cotes 1960) . All have therefore been combined in considering the relevance of indices of lung function to prognosis. The findings are summarized in Table 3 . These conclusions apply to subjects who span the whole range of lung function from normal to gross impairment. They do not necessarily apply to subdivisions of the group, particularly to those who are very disabled. Here indices related to increased airway resistance and airway closure are less sensitive than those which follow from unequal gas distribution. This is demonstrated by the results of an analysis of lung function, in relation to twelve months' mortality experience, in 67 subjects with advanced chronic lung disease, which are summarized in Table 4 (Cotes 1960) . On the left of this table are indices which are unrelated to prognosis over this period. Apart from body weight they include all the indices which are of prognostic value over the longer period. On the right are indices which are related to short-term prognosis in these disabled men. They include a reduction in maximum exercise ability on the treadmill, which is a refined version of the clinical grade of breathlessness, and a low arterial blood oxygen tension. This is due to the next item, ventilation perfusion inequality (Riley et al. 1951) , which is a consequence of unequal gas distribution. The two together cause a rise in pulmonary arterial pressure which was not measured directly Arterial blood CO, tension Right ventricular hypertrophy Category of pneumoconiosis in this series, hence ECG changes of right ventricular hypertrophy. Finally the occurrence during exercise of hypoventilation when the subject breathes oxygen instead of air, is also a bad prognostic sign. This is associated with an increase in exercise ability when oxygen is breathed (Cotes & Gilson 1956 ).
All these indices are consequences of ventilation perfusion inequality. This suggests that when such data are more widely available, as a result of the development of new methods for their assessment (West etal. 1957 , Klocke & Rahn 1961 , they will prove to be the best indicators of prognosis in chronic non-specific lung disease. 'Chronic bronchitis' as we understand it is more of a symptom-complex than syndrome with dramatic physical signs. A productive cough with sputum followed later by wheezing and breathlessness are the features. This undramatic and familiar condition is nevertheless so frequent in Britain that it has earned the eponym of the 'English disease'. Its implications on general practice are tremendous, for of men over the age of 50 more than one-third suffer clinically from 'chronic bronchitis' and each year the family doctor in an urban or industrial practice will be treating between 50 and 100 patients for acute exacerbations of bronchitis or bronchopneumonia.
Diagnosis
The early diagnosis of 'chronic bronchitis' is sometimes difficult, because the symptoms are no more than cough and sputum which are often, with good reason, put down to a 'smoker's cough'. The questionnaires prepared for recent surveys have used the following criteria: the expectoration of phlegm in the mornings in winter, bouts of cough and phlegm for at least three weeks for more than two winters and some breathlessness on walking at a normal pace. Assessment of function is even more difficult because so much reliance has to be placed on subjective statements and it is particularly difficult to compare the degree of subjective symptoms such as breathlessness from one year to the next. With the Wright peak flow meter some objective measure is now possible, and although the readings on the instrument are liable to variation depending on factors such as the technique used and the intelligence and co-operation of the patient, as a rule the differences between disabled bronchitics and others are so gross that the instrument can be a useful measure of functional changes. (1) Diagnosis: I keep a register of my chronic bronchitics in a card-index and so I am able to follow them. I endeavour to diagnose them early so that preventive measures may at least be given a chance. Although the diagnosis of 'chronic bronchitis' is essentially symptomatic, steps must be taken to exclude conditions with similar symptoms such as pulmonary tuberculosis, bronchial cancer, bronchiectasis and pneumoconiosis. A chest X-ray is essential in the early stages and preferably should be repeated every two or three years. Sputum examinations are also useful on occasions. Having a Wright peak flow meter I use it periodically to assess function. In making the diagnosis, consideration should be given to possible wetiological factors.
(2) Preventive measures: Of the greatest practical importance is the advice to patients to give up smoking. It can, of course, never be anything more than advice and it is disappointing to see how few are able to accept it. Advice may also be given on occupational risks, prevention of infections and possibly on site of residence -but the best advice is that which is also a practical possibility. It is no use advising an ordinary working man to winter on the Riviera or to retire at 55.
(3) Drugs: Antibiotics: My own routine is first to try the effects of large doses, 2 mega units daily of intramuscular crystalline penicillin for acute infective exacerbations. In the majority, the clinical response is good. If there is no improvement within forty-eight to seventy-two hours then a broad spectrum tetracycline is given. Only very few patients are given a small supply of a tetracycline to use when they suffer an acute episode with purulent sputum. I have no patients on continuous antibiotics. Corticosteroids: There is a very small place for these drugs in the management of bronchitics with dyspn(ca associated with bronchospasm. A trial of 10-15 mg of prednisone shows, within three or four days, whether there is any indication for these expensive and potentially dangerous drugs. 
